EU REGULATOR APPROVED ARTHRITIS DRUG FOR SEVERE COVID CASES
Tue 07 December 2021: In a statement released on Monday, the European Medicines Agency recommended the use of an anti-inflammatory arthritis drug for severe COVID-19 patients because it lowers the risk of death. The European Medicines Agency (EMA) human medicines committee “has recommended extending the indication of RoActemra to include the treatment of adults with […]
Continue Reading
